332 related articles for article (PubMed ID: 35076022)
1. Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy.
De Louche CD; Roghanian A
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 35076022
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte immunoglobulin-like receptors in health and disease.
Redondo-García S; Barritt C; Papagregoriou C; Yeboah M; Frendeus B; Cragg MS; Roghanian A
Front Immunol; 2023; 14():1282874. PubMed ID: 38022598
[TBL] [Abstract][Full Text] [Related]
3. Regulation of immune and neural function via leukocyte Ig-like receptors.
Takeda K; Nakamura A
J Biochem; 2017 Aug; 162(2):73-80. PubMed ID: 28898976
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.
Kang X; Kim J; Deng M; John S; Chen H; Wu G; Phan H; Zhang CC
Cell Cycle; 2016; 15(1):25-40. PubMed ID: 26636629
[TBL] [Abstract][Full Text] [Related]
5. Expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium: correlations to disease activity.
Tedla N; An H; Borges L; Vollmer-Conna U; Bryant K; Geczy C; McNeil HP
Tissue Antigens; 2011 Apr; 77(4):305-16. PubMed ID: 21388353
[TBL] [Abstract][Full Text] [Related]
6. LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.
Xiang Z; Yin X; Wei L; Peng M; Zhu Q; Lu X; Guo J; Zhang J; Li X; Zou Y
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397424
[TBL] [Abstract][Full Text] [Related]
7. The Role of Leukocyte Immunoglobulin-Like Receptors Focusing on the Therapeutic Implications of the Subfamily B2.
Hu Y; Lu X; Qiu W; Liu H; Wang Q; Chen Y; Liu W; Feng F; Sun H
Curr Drug Targets; 2022; 23(15):1430-1452. PubMed ID: 36017847
[TBL] [Abstract][Full Text] [Related]
8. Research progress of B subfamily of leucocyte immunoglobulin-like receptors in inflammation.
Zhang M; Yang J; Zhang J; Huang C; Liu H; Zhang P; Zhai Y; Liu L; Yang J
Int J Immunogenet; 2023 Jun; 50(3):107-116. PubMed ID: 37038910
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics.
Abdallah F; Coindre S; Gardet M; Meurisse F; Naji A; Suganuma N; Abi-Rached L; Lambotte O; Favier B
Front Immunol; 2021; 12():717998. PubMed ID: 34594332
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.
Deng M; Chen H; Liu X; Huang R; He Y; Yoo B; Xie J; John S; Zhang N; An Z; Zhang CC
Antib Ther; 2021 Jan; 4(1):16-33. PubMed ID: 33928233
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory leukocyte immunoglobulin-like receptors in cancer development.
Zhang F; Zheng J; Kang X; Deng M; Lu Z; Kim J; Zhang C
Sci China Life Sci; 2015 Dec; 58(12):1216-25. PubMed ID: 26566804
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of inflammatory responses by leukocyte Ig-like receptors.
Katz HR
Adv Immunol; 2006; 91():251-72. PubMed ID: 16938543
[TBL] [Abstract][Full Text] [Related]
13. Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells.
Anderson KJ; Allen RL
Immunology; 2009 May; 127(1):8-17. PubMed ID: 19368561
[TBL] [Abstract][Full Text] [Related]
14. A perspective on LILRBs and LAIR1 as immune checkpoint targets for cancer treatment.
Zhang CC
Biochem Biophys Res Commun; 2022 Dec; 633():64-67. PubMed ID: 36344166
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies.
Zhang J; Mai S; Chen HM; Kang K; Li XC; Chen SH; Pan PY
J Leukoc Biol; 2017 Aug; 102(2):351-360. PubMed ID: 28351852
[TBL] [Abstract][Full Text] [Related]
16. Cloning of rhesus monkey LILRs.
Slukvin II; Grendell RL; Rao DS; Hughes AL; Golos TG
Tissue Antigens; 2006 Apr; 67(4):331-7. PubMed ID: 16634871
[TBL] [Abstract][Full Text] [Related]
17. The LILR family: modulators of innate and adaptive immune pathways in health and disease.
Brown D; Trowsdale J; Allen R
Tissue Antigens; 2004 Sep; 64(3):215-25. PubMed ID: 15304001
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.
Cheng H; Mohammed F; Nam G; Chen Y; Qi J; Garner LI; Allen RL; Yan J; Willcox BE; Gao GF
J Biol Chem; 2011 May; 286(20):18013-25. PubMed ID: 21454581
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of Carassius auratus-leukocyte-immune-type receptors (CaLITRs) during goldfish kidney macrophage development and in activated kidney leukocyte cultures.
Wang J; Soliman AM; Norlin J; Barreda DR; Stafford JL
Immunogenetics; 2023 Apr; 75(2):171-189. PubMed ID: 36806761
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells.
Tedla N; Lee CW; Borges L; Geczy CL; Arm JP
J Leukoc Biol; 2008 Feb; 83(2):334-43. PubMed ID: 17998301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
